Angiogenesis Inhibitors: all 4,430 studies that test it
Page 37 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine GliomasCompletedNCT00890786Early Phase 1
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal CancerStatus unknownNCT00890188Phase 2
- Safety/Biomarker Study of CNTO 95 and Avastin in Solid TumorsCompletedNCT00888043Phase 1
- A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerCompletedNCT00887536Phase 3
- A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsCompletedNCT00886132Phase 2
- Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)Status unknownNCT00885794Phase 2/3
- A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5qStatus unknownNCT00885508Phase 2
- N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk NeuroblastomaCompletedNCT00885326Phase 1
- Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid TumorsCompletedNCT00884676Phase 1
- A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) AmyloidosisCompletedNCT00883623Phase 2
- A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer PatientsCompletedNCT00876044Phase 1
- Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer PatientsCompletedNCT00875771Phase 2
- The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) AbnormalityCompletedNCT00874978Phase 2
- Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular EdemaCompletedNCT00874744Phase 2
- A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal CancerCompletedNCT00873756Phase 1
- Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal CancerCompletedNCT00873275Phase 1
- A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular CancerCompletedNCT00872014Phase 2
- Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior TherapyActive, not recruitingNCT00871013Phase 2
- UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionActive, not recruitingNCT00869232Phase 2
- Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)CompletedNCT00864942Phase 1
- Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent GlioblastomaCompletedNCT00864864Early Phase 1
- Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)CompletedNCT00862342Phase 2
- To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.CompletedNCT00861419Phase 1
- Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon ResistanceStatus unknownNCT00856804Phase 2
- Subconjunctival Bevacizumab Effect on Bleb VascularityStatus unknownNCT00854529Phase 2
- Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal CancerStatus unknownNCT00853684Phase 2
- A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)CompletedNCT00851136Phase 1
- Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal CancerCompletedNCT00851045Phase 2
- Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung CancerTerminatedNCT00850577Phase 2
- Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.CompletedNCT00849550Phase 1
- Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma PatientsCompletedNCT00849264Phase 2
- Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin LymphomaTerminatedNCT00848328Phase 2
- Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple MyelomaCompletedNCT00847639Phase 2
- Xeloda and Bevacizumab to Treat Rectal CancerCompletedNCT00847119Phase 2
- Study of Uveitic Macular Edema Treated With Ranibizumab or SteroidsWithdrawnNCT00846625Phase 2
- Pharmacokinetic Study of Avastin and Doxil in Ovarian CancerCompletedNCT00846612Phase 1
- Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric CancerStatus unknownNCT00845884Phase 1/2
- Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWithdrawnNCT00845104Phase 2
- Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II StudyCompletedNCT00843440Phase 2
- Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II StudyStatus unknownNCT00842686Phase 2
- Lucentis to Treat Pigment Epithelial DetachmentCompletedNCT00841581Phase 2
- Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)CompletedNCT00840931Phase 1
- Lenalidomide In Patients With Acute Myeloid LeukemiaTerminatedNCT00839059Phase 1
- Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis EvaluationsCompletedNCT00831350Phase 2
- A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic LeukemiaWithdrawnNCT00829647Phase 1/2
- Lenalidomide and Decitabine in High Grade Myelodysplastic SyndromesCompletedNCT00828802Phase 1
- Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) PatientsCompletedNCT00826371Phase 3
- Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer PatientsCompletedNCT00820547Phase 2
- Activity Study of Sunitinib In Metastatic Pretreated Urothelial CancerStatus unknownNCT00818350Phase 1/2
- Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)CompletedNCT00817284Phase 2
- Bleb Vascularity Change After Subconjunctival Injection BevacizumabStatus unknownNCT00815594Phase 4
- Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the BrainCompletedNCT00814021Phase 2
- Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular DegenerationStatus unknownNCT00813891Phase 4
- Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced MelanomaStatus unknownNCT00813449Phase 2
- Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to ChemotherapyCompletedNCT00813423Phase 1
- Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)Status unknownNCT00813332Phase 4
- FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal CancerStatus unknownNCT00813137Phase 2
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
- Treatment Of Radiation Retinopathy TrialStatus unknownNCT00811200Phase 2/3
- Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast CancerCompletedNCT00807859Phase 1
- FOLFIRI and Sunitinib in Metastatic Colorectal CancerCompletedNCT00806663Phase 2
- Combined Triple Therapy in Diabetic Retinopathy (DRP)CompletedNCT00806169Phase 3
- Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary CirrhosisCompletedNCT00805805Phase 3
- Combined Triple Procedure in Retinal Vein Occlusion (RVO)CompletedNCT00805064Phase 3
- Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After BevacizumabCompletedNCT00804921Phase 2
- Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid CancerTerminatedNCT00804830Phase 2
- Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal PhotocoagulationTerminatedNCT00804206Phase 4
- Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)CompletedNCT00802906Not applicable
- Avastin for Post-photocoagulation Macular EdemaWithdrawnNCT00801866Phase 4
- A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma MultiformeCompletedNCT00800917Phase 2
- The Effect of Bevacizumab on Corneal NeovascularizationCompletedNCT00797303Phase 4
- Study of IMC-1121B in Patients With Tumors That Have Not Responded to TherapyCompletedNCT00793975Phase 1
- A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMDCompletedNCT00793923Phase 1/2
- Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell CancerCompletedNCT00792025Phase 2
- Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical ProstatectomyCompletedNCT00790595Phase 1
- R-CHOP-B Bevacizumab for Diffuse Large B Cell LymphomaTerminatedNCT00788606Phase 2
- A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell CarcinomaCompletedNCT00788060Phase 1
- Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDEWithdrawnNCT00787436Phase 3
- Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)CompletedNCT00786851Phase 2
- A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid TumorsCompletedNCT00786669Phase 1
- Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard TherapyCompletedNCT00786383Phase 1
- Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 YearsCompletedNCT00783653Phase 1/2
- A Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular DegenerationCompletedNCT00782093Phase 1
- Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)CompletedNCT00781846Phase 1
- Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal FunctionCompletedNCT00779922Phase 2
- Dose-finding of Lenalidomide as Maintenance in Multiple MyelomaCompletedNCT00778752Phase 1/2
- Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.Status unknownNCT00777673Phase 2
- Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001CompletedNCT00775073Phase 2
- A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerCompletedNCT00773695Phase 2
- AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CRCompletedNCT00770536Phase 1
- Thalidomide in Treating Patients With Relapsed or Progressive Systemic MastocytosisCompletedNCT00769587
- Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant SurgeryCompletedNCT00769145Phase 1
- Ranibizumab for the Inhibition of Neovascularization in PterygiaCompletedNCT00768963Phase 1
- Ranibizumab in Combination With Proton Beam Irradiation for Choroidal MelanomaCompletedNCT00765921Phase 1
- A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent GlioblastomaCompletedNCT00762255Phase 1
- Doxil, Bevacizumab and Temsirolimus TrialCompletedNCT00761644Phase 1
- Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5CompletedNCT00761449Phase 2
- A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid TumorsCompletedNCT00756340Phase 1
- Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung CancerCompletedNCT00755170Phase 2